EP2222300
Aðferð og efnasamband við meðhöndlun á viðtakaháðum serótónín-sjúkdómi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.12.2008EP published:
11.6.2014EP application number:
08859016.1
EP translation filed:
21.7.2014Grant published:
15.8.2014EPO information:
European Patent Register
Max expiry date:
12.12.2028Expiry date:
12.12.2026Next due date:
31.12.2026
Title:
METHOD AND COMPOSITION FOR TREATING A SEROTONIN RECEPTOR-MEDIATED CONDITION
Timeline
Owner
Name:
Vanda Pharmaceuticals Inc.Address:
2200 Pennsylvania Avenue, 20037, Washington, DC, US
Inventor
Name:
POLYMEROPOULOS, Mihael, H.Address:
PotomacMD, US
Name:
BAROLDI, PaoloAddress:
Potomac, Maryland, US
Name:
WOLFGANG, Curt, D.Address:
GermantownMD, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
13377Date:
13.12.2007Country:
US
Classification
Categories:
A61K 31/445, A61P 7/02, A61P 9/10, A61P 25/02
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 20.11.2014
Expires: 12.12.2015
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 18.11.2015
Expires: 12.12.2016
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 18.11.2016
Expires: 12.12.2017
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 20.11.2017
Expires: 12.12.2018
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 20.11.2018
Expires: 12.12.2019
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 19.11.2019
Expires: 12.12.2020
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 18.11.2020
Expires: 12.12.2021
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 18.11.2021
Expires: 12.12.2022
Payer: Sigurjónsson & Thor ehf.
Number: 15
Paid: 21.11.2022
Expires: 12.12.2023
Payer: Árnason Faktor ehf.
Number: 16
Paid: 23.11.2023
Expires: 12.12.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 20.11.2024
Expires: 12.12.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 11.12.2025
Expires: 12.12.2026
Payer: Árnason Faktor ehf.